Last reviewed · How we verify
Influenza Hemagglutinin mRNA vaccine — Competitive Intelligence Brief
phase 1
Biologic
Live · refreshed every 30 min
Target snapshot
Influenza Hemagglutinin mRNA vaccine (Influenza Hemagglutinin mRNA vaccine) — Sanofi Pasteur, a Sanofi Company.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Influenza Hemagglutinin mRNA vaccine TARGET | Influenza Hemagglutinin mRNA vaccine | Sanofi Pasteur, a Sanofi Company | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Influenza Hemagglutinin mRNA vaccine CI watch — RSS
- Influenza Hemagglutinin mRNA vaccine CI watch — Atom
- Influenza Hemagglutinin mRNA vaccine CI watch — JSON
- Influenza Hemagglutinin mRNA vaccine alone — RSS
Cite this brief
Drug Landscape (2026). Influenza Hemagglutinin mRNA vaccine — Competitive Intelligence Brief. https://druglandscape.com/ci/influenza-hemagglutinin-mrna-vaccine. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab